INGN logo

Inogen (INGN) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$125.49 M
-$61.52 M-32.90%

December 31, 2023


Summary


Performance

INGN Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINGNbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$105.69 M
+$7.77 M+7.94%

September 30, 2024


Summary


Performance

INGN Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINGNbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

INGN Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-32.9%-15.2%
3 y3 years-40.8%-15.2%
5 y5 years-36.2%-15.2%

INGN Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-46.7%at low-55.1%+7.9%
5 y5-year-46.7%at low-56.3%+7.9%
alltimeall time-46.7%+3112.8%-56.3%+681.7%

Inogen Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$105.69 M(+7.9%)
Jun 2024
-
$97.92 M(-8.9%)
Mar 2024
-
$107.44 M(-14.4%)
Dec 2023
$125.49 M(-32.9%)
$125.49 M(+0.7%)
Sep 2023
-
$124.61 M(-25.7%)
Jun 2023
-
$167.69 M(+2.2%)
Mar 2023
-
$164.14 M(-12.2%)
Dec 2022
$187.01 M(-20.6%)
$187.01 M(-10.8%)
Sep 2022
-
$209.63 M(-6.3%)
Jun 2022
-
$223.62 M(+4.8%)
Mar 2022
-
$213.40 M(-9.4%)
Dec 2021
$235.52 M(+11.1%)
$235.52 M(-2.5%)
Sep 2021
-
$241.58 M(+1.1%)
Jun 2021
-
$238.85 M(+8.6%)
Mar 2021
-
$220.01 M(+3.8%)
Dec 2020
$211.96 M(+7.0%)
$211.96 M(-0.9%)
Sep 2020
-
$213.98 M(-0.0%)
Jun 2020
-
$214.09 M(+2.7%)
Mar 2020
-
$208.36 M(+5.2%)
Dec 2019
$198.04 M(+0.7%)
$198.04 M(+26.8%)
Sep 2019
-
$156.13 M(-27.0%)
Jun 2019
-
$213.95 M(+12.5%)
Mar 2019
-
$190.24 M(-3.3%)
DateAnnualQuarterly
Dec 2018
$196.63 M(+37.6%)
$196.63 M(+11.5%)
Sep 2018
-
$176.28 M(+6.0%)
Jun 2018
-
$166.34 M(+7.8%)
Mar 2018
-
$154.28 M(+7.9%)
Dec 2017
$142.95 M(+54.0%)
$142.95 M(+10.2%)
Sep 2017
-
$129.69 M(+13.1%)
Jun 2017
-
$114.71 M(+9.1%)
Mar 2017
-
$105.11 M(+13.2%)
Dec 2016
$92.85 M(+40.5%)
$92.85 M(+8.0%)
Sep 2016
-
$86.01 M(+1.8%)
Jun 2016
-
$84.50 M(+16.7%)
Mar 2016
-
$72.40 M(+9.5%)
Dec 2015
$66.11 M(+16.3%)
$66.11 M(+20.0%)
Sep 2015
-
$55.09 M(+6.3%)
Jun 2015
-
$51.82 M(-15.2%)
Mar 2015
-
$61.10 M(+7.5%)
Dec 2014
$56.84 M(+320.4%)
$56.84 M(+1.2%)
Sep 2014
-
$56.16 M(-18.7%)
Jun 2014
-
$69.05 M(+15.9%)
Mar 2014
-
$59.55 M(+340.4%)
Dec 2013
$13.52 M(-10.5%)
$13.52 M(-20.7%)
Sep 2013
-
$17.06 M(+12.9%)
Dec 2012
$15.11 M(+286.9%)
$15.11 M
Dec 2011
$3.91 M
-

FAQ

  • What is Inogen annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Inogen?
  • What is Inogen annual cash & cash equivalents year-on-year change?
  • What is Inogen quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Inogen?
  • What is Inogen quarterly cash and cash equivalents year-on-year change?

What is Inogen annual cash & cash equivalents?

The current annual cash & cash equivalents of INGN is $125.49 M

What is the all time high annual cash & cash equivalents for Inogen?

Inogen all-time high annual cash & cash equivalents is $235.52 M

What is Inogen annual cash & cash equivalents year-on-year change?

Over the past year, INGN annual cash & cash equivalents has changed by -$61.52 M (-32.90%)

What is Inogen quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of INGN is $105.69 M

What is the all time high quarterly cash and cash equivalents for Inogen?

Inogen all-time high quarterly cash and cash equivalents is $241.58 M

What is Inogen quarterly cash and cash equivalents year-on-year change?

Over the past year, INGN quarterly cash and cash equivalents has changed by -$18.92 M (-15.18%)